Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Sacroiliitis Treatment Market Heading Into 2029?

In recent times, the sacroiliitis treatment market has witnessed robust growth. It is projected to augment from $1.64 billion in 2024 to about $1.77 billion in 2025, adhering to a compound annual growth rate (CAGR) of 7.5%. The significant growth observed in the historic period is credited to factors such as a spike in lower back pain cases, heightened interest in early detection, increase in pelvic injuries associated with sports, growing application of sophisticated imaging modalities, and a mounting emphasis on minimally invasive therapies.

Expectations are high for robust growth in the sacroiliitis treatment market as it is predicted to reach a value of $2.33 billion by 2029, with a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this projected growth include an increase in R&D investments for unique therapies, a higher adoption rate of telemedicine for managing chronic pain, rising occurrences of autoimmune diseases, more accessible targeted biologic treatments, and a growing demand for bespoke medicine strategies. The forecast period also highlights several key trends such as the progression of targeted drug delivery systems, the creation of personalized treatment models, breakthroughs in regenerative medicinal therapies, advancements in robot-assisted surgical processes, and the development of combined therapy procedures.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24688&type=smp

Which Factors Are Pushing The Sacroiliitis Treatment Market Forward?

The rising instances of joint ailments are anticipated to boost the sacroiliitis treatment market’s expansion. Joint disorders, which cause discomfort, inflammation, rigidity, and compromised mobility due to factors such as injury, ageing, autoimmune conditions, or infections, are conditions affecting the joints. The predominance of joint disorders is primarily amplified because elderly groups suffer natural degradation of their joints, hence escalating the occurrence of conditions like osteoarthritis and other degenerative joint diseases. Sacroiliitis treatment helps manage joint disorders by alleviating inflammation and discomfort in the sacroiliac joints, enhancing mobility and overall joint function, potentially providing relief from symptoms and forestalling further joint deterioration. For example, the Australian Institute of Health and Welfare, a government organisation based in Australia, stated in June 2024 that osteoarthritis, a long-term condition typified by joint cartilage degradation, had an impact on approximately 2.1 million Australians (8.3%) in 2022, including 10% of women and 6.1% of men. Consequently, the escalating instances of joint disorders are stimulating the growth of the sacroiliitis treatment market.

Which Segment Held The Largest Share In The Sacroiliitis Treatment Market In 2025?

The sacroiliitis treatment market covered in this report is segmented –

1) By Type: Medications, Joint Injections, Joint Fusion, Radiofrequency Denervation, Electrical Stimulation

2) By Diagnosis: Imaging Tests, Physical Examination, Laboratory Tests, Other Diagnosis

3) By Route Of Administration: Oral, Injectable, Topical

4) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: NSAIDs (Nonsteroidal Anti-Inflammatory Drugs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Agents, Analgesics

2) By Joint Injections: Corticosteroid Injections, Platelet-Rich Plasma (PRP) Injections, Hyaluronic Acid Injections, Prolotherapy

3) By Joint Fusion: Minimally Invasive SI Joint Fusion, Open SI Joint Fusion, Robotic-Assisted Fusion Techniques, Posterior Approach Fusion, Lateral Approach Fusion

4) By Radiofrequency Denervation: Conventional Radiofrequency Ablation, Cooled Radiofrequency Ablation, Pulsed Radiofrequency Ablation

5) By Electrical Stimulation: Transcutaneous Electrical Nerve Stimulation (TENS), Spinal Cord Stimulation (SCS), Peripheral Nerve Stimulation (PNS)

How Are Key Trends Driving Expansion In The Sacroiliitis Treatment Industry?

To hastily introduce innovative remedies, secure access to the market, and boost their competitive stance, leading organizations in the sacroiliitis treatment industry make regulatory approvals a priority. These permissions are essentially an affirmation from government health bodies that a medical treatment is both safe and effective for the general public. An example of this occurred in December 2023 when Spinal Simplicity, an American medical equipment production firm, obtained FDA 510(k) clearance for their Liberty-SI Lateral Implant System. This system, designed for sacroiliac joint fusion in patients with sacroiliac disturbances and degenerative sacroiliitis, utilizes a minimal invasive approach. One or two titanium implants are inserted through the ilium and across the SI joint into the sacrum, thereby offering stabilization and fusion. The implants have a central threaded body with deployable wings and compressive elements and come in various sizes. They are also coated with hydroxyapatite to facilitate integration. The procedure is geared to be safer and less invasive, potentially lessening anesthesia duration and enhancing patient results.

Which Organizations Are Driving Progress In The Sacroiliitis Treatment Industry?

Major companies operating in the sacroiliitis treatment market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Biogen Inc., Sandoz Group AG, UCB S.A., Hikma Pharmaceuticals PLC, Samsung Bioepis Co. Ltd., Lupin Limited, Zydus Lifesciences Limited, Celltrion Healthcare Co. Ltd., Torrent Pharmaceuticals Limited, Globus Medical, Fortis Healthcare, Orthofix Medical Inc., Coherus BioSciences Inc., SI-BONE Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/sacroiliitis-treatment-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Sacroiliitis Treatment Industry?

North America was the largest region in the sacroiliitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacroiliitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24688&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model